The First Affiliated Hospital of Chongqing Medical University
Chongqing, 400016, China
Location status: Recruiting
NCT Number: NCT07163013
CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
Interested in participating?
Request Info12 year–18 year
All sexes
Interventional
Not applicable
Chongqing, 400016, China
Location status: Recruiting
CADS-D is a single-center, two-arm, open-label randomized controlled trial. The trial targeted 12-18 years adolescents with depressive symptoms. Intervention group receives the digital cognitive behavioral therapy (DCBT) program for 6 weeks, while the control group receives the regular mental health curriculum provided by school staff for 6 weeks. Assessments are conducted at three time points: baseline, post-intervention (6 weeks), and at 3 months follow-up (18 weeks). The primary outcome is the effectiveness of DCBT. Secondary outcomes include the feasibility of DCBT, self-reported depressive severity, anxiety severity, psychological resilience, and the quality of life enjoyment and satisfaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Moca is a mobile application designed to deliver structural CBT for adolescents with mood problems. Moca provides six-twelve guided sessions with an estimated proceeding duration of 25-45min each, developed to be processed weekly. The content of each session includes the introduction of the core concepts and principles of CBT, psychological counseling dialogue, skill exercises, and homework. Content presentation forms include text, animation, audio, comics, etc. At the end of each module, the participants will be asked to submit homework that will ask them to apply their learned skills to nursing or daily life situations that they personally perceive as stressful. Participants can review the completed sessions and record their mood status during the intervention period.
The content of regular mental health curriculum includes mental health education lecture. Few lectures address the knowledge and skills involved in CBT in such education lecture.
Time frame: Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks)
Children's Depression Rating Scale is a 17 items observer-rated scale developed specifically for children and adolescents. Total scores range from 17-113, with higher scores indicating greater severity of depressive symptoms.
Time frame: 6 weeks
Feasibility is assessmented by an acceptability and satisfaction questionnaire. The questionnaire constitutes 10 items which designed to examine acceptability and satisfaction with DCBT. In the first 8 questions, participants rated each item on a 5-point Likert scale. In last 2 questions, participants are asked to write the best and worst things about DCBT.
Time frame: Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks)
Improvement in self-reported depressive symptoms. Total scores range from 0-27, with higher scores indicating greater severity of self-reported depressive symptoms.
Time frame: Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks)
Improvement in self-reported anxiety symptom. Total scores range from 0-21, with higher scores indicating greater severity of self-reported anxiety symptoms.
Time frame: Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks)
Improvement in psychological resilience assessed by Connor-Davidson Resilience Scale. Total scores range from 0-100, with higher total scores indicating stronger psychological resilience.
Time frame: Baseline of intervention period, 6 weeks, and 3 months follow-up (18 weeks)
Improvement of adolescents' quality of life. The total scores range from 14-70,with higher scores indicating greater enjoyment and satisfaction with life.
Contact information is provided by the study sponsor or research team.
First Affiliated Hospital of Chongqing Medical University
Other
Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D ): A Randomized Clinical Trial
Acronym: CADS-D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631845
Anxiety, Anxiety Disorders
Hong Kong
View Trial DetailsNCT06752759
Analgesics, Non-Narcotic, Anesthetics Agent
Brooklyn, New York, United States
View Trial DetailsNCT07305415
BPSD (Behavioral and Psycological Symptoms of Dementia), Behavior
Hong Kong
View Trial DetailsNCT07165925
Anxiety, Anxiety Disorders
Hong Kong
View Trial Details